Literature DB >> 307364

Antimicrobial susceptibility of Haemophilus ducreyi.

G W Hammond, C J Lian, J C Wilt, A R Ronald.   

Abstract

The susceptibility of 19 isolates of Haemophilus ducreyi from a recent chancroid outbreak and four reference strains was determined in vitro to 13 antimicrobial agents. The rabbit intradermal test for virulence was positive for all of the local isolates, but not for the reference strains. The "nonvirulent" reference strains were inhibited by lower minimum inhibitory concentrations (MICs) of most agents tested. For the virulent isolates, the range of MICs (in micrograms per milliliter) of the following were: of vancomycin, 8 to 128; of polymyxin, 32 to 128; of cloxacillin, 32 to 64; of tetracycline, 0.5 to 32; of cephalothin, 4 to 8; of doxycycline, 0.25 to 8; and of kanamycin, 1 to 8. Three strains were resistant to penicillin and ampicillin (MIC >/= 128 mug/ml), and these three strains produced beta-lactamase. The remainder were susceptible to 4 mug/ml. All strains were susceptible to rifampin (MIC </= 1 mug/ml), chloramphenicol (MIC </= 4 mug/ml), sulfisoxazole (MIC </= 8 mug/ml), and nalidixic acid (MIC </= 8 mug/ml). These susceptibilities of H. ducreyi indicate several antimicrobial agents that may be effective for chancroid treatment and support the use of vancomycin in a selective medium for the culture of chancroid genital ulcers.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307364      PMCID: PMC352296          DOI: 10.1128/AAC.13.4.608

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Effects of penicillin G in vitro on Hemophilus ducreyi.

Authors:  W E DEACON; S SINGER
Journal:  Public Health Rep       Date:  1956-11       Impact factor: 2.792

2.  V.D.R.L. chancroid studies. III. Use of Ducrey skin test vaccines on rabbits.

Authors:  W KAPLAN; W E DEACON; S OLANSKY; D C ALBRITTON
Journal:  J Invest Dermatol       Date:  1956-05       Impact factor: 8.551

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  The management of resistant chancroid in Vietnam.

Authors:  J L Marmar
Journal:  J Urol       Date:  1972-05       Impact factor: 7.450

5.  Treatment of chancroid. A comparison of tetracycline and sulfisoxazole.

Authors:  R E Kerber; C E Rowe; K R Gilbert
Journal:  Arch Dermatol       Date:  1969-11

6.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

7.  Venereal disease in a war environment: incidence and management.

Authors:  G Hart
Journal:  Med J Aust       Date:  1975-06-28       Impact factor: 7.738

8.  Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi.

Authors:  G W Hammond; C J Lian; J C Wilt; A R Ronald
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

  9 in total
  64 in total

1.  Expression of the cytolethal distending toxin in a geographically diverse collection of Haemophilus ducreyi clinical isolates.

Authors:  K Kulkarni; D A Lewis; C A Ison
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

2.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Haemophilus ducreyi, a cytotoxin-producing bacterium.

Authors:  M Purvén; T Lagergård
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 4.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 5.  Treatment of chancroid.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

6.  Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Haemophilus ducreyi attaches to and invades human epithelial cells in vitro.

Authors:  P A Totten; J C Lara; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.

Authors:  Kristy L B Mount; Carisa A Townsend; Sherri D Rinker; Xiaoping Gu; Kate R Fortney; Beth W Zwickl; Diane M Janowicz; Stanley M Spinola; Barry P Katz; Margaret E Bauer
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

10.  Plasmid-mediated tetracycline resistance in Haemophilus ducreyi.

Authors:  W L Albritton; I W Maclean; L A Slaney; A R Ronald; H G Deneer
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.